July 29, 2019

Funds will support UK commercial launch and FDA 510(k) submission later this year

Alcester, Warwickshire, UK, 29 July 2019: Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home…

Continue Reading